• 1. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 2. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 3. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disorders
  Jie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
• 4. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 5. An assay for the enzyme N-acetyl-β-d-glucosaminidase (NAGase) based on electrochemical detection using screen-printed carbon electrodes (SPCEs)
  R. M. Pemberton,J. P. Hart,T. T. Mottram Analyst, 2001,126, 1866-1871

Introduction to 2-(4-Aminophenyl)-N-methylacetamide (CAS No. 32637-62-0)

2-(4-Aminophenyl)-N-methylacetamide, identified by its Chemical Abstracts Service (CAS) number 32637-62-0, is a significant compound in the realm of pharmaceutical and chemical research. This amide derivative features a unique structural framework that has garnered attention for its potential applications in medicinal chemistry and synthetic organic chemistry. The presence of both an amino group and a methyl-substituted acetamide moiety makes it a versatile intermediate for the development of various bioactive molecules.

The compound's molecular structure, characterized by a phenyl ring substituted with an amino group at the para position and an N-methylacetamide side chain, contributes to its reactivity and functional diversity. Such structural motifs are frequently explored in the design of pharmacophores, which are key structural elements responsible for the biological activity of drugs. The combination of aromatic and amide functionalities provides a scaffold that can be modified to target specific biological pathways, making 2-(4-Aminophenyl)-N-methylacetamide a valuable building block in drug discovery.

In recent years, there has been growing interest in amide-based compounds due to their broad spectrum of biological activities. Amides are known for their stability, solubility, and ability to interact with biological targets such as enzymes and receptors. The research community has been actively investigating how modifications to the amide backbone can enhance or alter the pharmacological properties of these compounds. For instance, studies have demonstrated that introducing electron-withdrawing or electron-donating groups into the amide moiety can modulate its interactions with biological targets, leading to improved efficacy or selectivity.

One of the most compelling aspects of 2-(4-Aminophenyl)-N-methylacetamide is its potential as a precursor for the synthesis of more complex molecules. The amino group at the para position of the phenyl ring can undergo further functionalization, such as acylation, alkylation, or coupling reactions, to introduce additional pharmacophoric elements. Similarly, the N-methylacetamide side chain can be modified to enhance solubility, bioavailability, or metabolic stability. These properties make it an attractive candidate for use in library synthesis programs aimed at identifying novel therapeutic agents.

The pharmaceutical industry has long recognized the importance of intermediates like 2-(4-Aminophenyl)-N-methylacetamide in drug development. Many blockbuster drugs on the market today were synthesized using similar amide-based intermediates. For example, nonsteroidal anti-inflammatory drugs (NSAIDs) often incorporate amide functionalities to achieve their desired pharmacological effects. By leveraging compounds like 32637-62-0, researchers can accelerate the discovery and development of new drugs with improved pharmacokinetic profiles and reduced side effects.

Recent advances in computational chemistry have further enhanced the utility of 2-(4-Aminophenyl)-N-methylacetamide as a research tool. High-throughput virtual screening (HTVS) and molecular docking techniques allow researchers to predict how different modifications to this compound might affect its binding affinity to biological targets. These computational methods have become indispensable in modern drug discovery pipelines, enabling scientists to rapidly screen large libraries of compounds for potential leads.

In addition to its pharmaceutical applications, 2-(4-Aminophenyl)-N-methylacetamide has shown promise in materials science and industrial chemistry. Its unique structural features make it suitable for use as a ligand in catalytic systems or as a precursor for advanced polymers with specialized properties. The ability to fine-tune its chemical behavior through strategic functionalization opens up numerous possibilities for innovation across multiple scientific disciplines.

The synthesis of 32637-62-0 is another area where significant progress has been made. Modern synthetic methodologies have enabled more efficient and scalable production processes for this compound. Techniques such as flow chemistry and microwave-assisted synthesis have reduced reaction times and improved yields, making it more accessible for both academic research and industrial applications. These advancements underscore the importance of continuous innovation in synthetic chemistry to meet the growing demand for high-quality intermediates like 2-(4-Aminophenyl)-N-methylacetamide.

The safety and regulatory considerations associated with CAS No 32637-62-0 are also critical factors that influence its use in research and industry. While this compound is not classified as hazardous under standard conditions, proper handling procedures must be followed to ensure worker safety and environmental protection. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) provide guidelines for the safe handling, storage, and disposal of chemical intermediates used in drug development.

Future directions in research involving 2-(4-Aminophenyl)-N-methylacetamide may focus on exploring its potential in emerging therapeutic areas such as oncology, neurology, and infectious diseases. The ability to modify its structure allows researchers to tailor its properties for specific biological targets, making it a versatile tool for addressing unmet medical needs. As our understanding of disease mechanisms continues to evolve, compounds like 32637-62-0 will play an increasingly important role in developing next-generation therapeutics.

In conclusion,2-(4-Aminophenyl)-N-methylacetamide (CAS No 32637-62-0) is a multifaceted compound with significant potential across multiple scientific disciplines. Its unique structural features make it an invaluable intermediate for pharmaceutical research, while its adaptability allows for further functionalization into more complex molecules. With ongoing advancements in synthetic chemistry and computational methods,32637-62-0 will continue to be a cornerstone in drug discovery efforts aimed at improving human health.

• 6830-82-6(N-Methyl-2-phenylacetamide)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)